Literature DB >> 10594270

Laparoscopic vs open splenectomy in the management of hematologic diseases.

A Donini1, U Baccarani, G Terrosu, V Corno, A Ermacora, A Pasqualucci, F Bresadola.   

Abstract

BACKGROUND: Laparoscopic splenectomy (LS) is becoming the gold standard in the treatment of several splenic diseases. Shorter postoperative stay and more rapid return to full activity are the primary advantages of LS.
METHODS: Prospective data collection of 44 consecutive LS (group 1) and comparison with a historical control group of 56 consecutive open splenectomies (OS) (group 2) were performed for hematologic diseases.
RESULTS: The LS patients started earlier on an oral diet (p < 0.0001) and left the hospital sooner (p < 0.0002) than OS patients. Less blood transfusion (p < 0.004) and pain medication (p < 0.0001) was required by LS patients. They also had fewer postoperative complications (p < 0.03). Compared by diagnosis, patients with laparoscopic idiopathic thrombocytopenic purpura or Hodgkin's disease started to eat earlier (p < 0.0001) and left the hospital sooner (p < 0.01). Multivariate analysis showed that time to oral diet and postoperative stay was related to operative technique and age. Morbidity and pain medications were related, respectively, to transfusion requirements and type of surgical approach.
CONCLUSIONS: Used to manage hematologic diseases, LS is feasible, effective, and safe. It offers several advantages over the open approach. The type of surgical approach seems to be the crucial factor in determining the length of the postoperative course.

Entities:  

Mesh:

Year:  1999        PMID: 10594270     DOI: 10.1007/pl00009625

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

1.  Determination of intact splenic weight based on morcellated weight.

Authors:  R M Walsh; B Chand; J Brodsky; B T Heniford
Journal:  Surg Endosc       Date:  2003-05-20       Impact factor: 4.584

Review 2.  Minimally invasive surgery.

Authors:  B Jaffray
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

3.  Laparoscopic splenectomy in the elderly: a morbid procedure?

Authors:  S M Kavic; R D Segan; A E Park
Journal:  Surg Endosc       Date:  2005-10-03       Impact factor: 4.584

4.  A critical comparison of robotic versus conventional laparoscopic splenectomies.

Authors:  Johannes Bodner; Reinhold Kafka-Ritsch; Paolo Lucciarini; John H Fish; Thomas Schmid
Journal:  World J Surg       Date:  2005-08       Impact factor: 3.352

5.  Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS).

Authors:  M Casaccia; P Torelli; S Squarcia; M P Sormani; A Savelli; B Troilo; G Santori; U Valente
Journal:  Surg Endosc       Date:  2006-07-03       Impact factor: 4.584

6.  Management of postoperative complications following splenectomy.

Authors:  Yikun Qu; Shiyan Ren; Chunmin Li; Songyi Qian; Peng Liu
Journal:  Int Surg       Date:  2013 Jan-Mar

7.  Laparoscopic splenectomy is a better surgical approach for spleen-relevant disorders: a comprehensive meta-analysis based on 15-year literatures.

Authors:  Ji Cheng; Kaixiong Tao; Peiwu Yu
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

8.  Laparoscopic splenectomy for hematological diseases.

Authors:  P Torelli; D Cavaliere; M Casaccia; F Panaro; P Grondona; E Rossi; G Santini; M Truini; M Gobbi; A Bacigalupo; U Valente
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

9.  Outcomes of laparoscopic versus open splenectomy.

Authors:  Hakan Bulus; Hatim Mahmoud; Hasan Altun; Adnan Tas; Kaan Karayalcin
Journal:  J Korean Surg Soc       Date:  2012-12-26

10.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.